Atypical Meningioma — Trials

Atypical Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02847559	Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma	completed	Phase 2	20	Northwestern UniversityOTHER	1	Sep 9, 2026	clinicaltrials
NCT04541082	Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms	recruiting	Phase 1	102	Jazz PharmaceuticalsINDUSTRY	1	Dec 18, 2025	clinicaltrials
NCT03016091	A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma	terminated	Phase 2	18	Rabin Medical CenterOTHER	1	Feb 18, 2025	clinicaltrials
NCT02973256	Oncological Care for Patients With Meningioma(ATYPICMENING)	unknown	—	1,204	University Hospital, Montpellier

Data updated 20 days agoSource updated Sep 9, 2026source: clinicaltrials